Emergent Biosolutions, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for EBS, updated each market day.
EBS AI Sentiment
AI sees no strong directional signal for Emergent Biosolutions, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Emergent Biosolutions, Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Sector
Exchange
Market Cap
$436,395,982
Cap Tier
Employees
900
Headquarters
GAITHERSBURG, MD
Listed Since
Nov. 15, 2006
EBS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
EBS Volatility
Emergent Biosolutions, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
